Veeva Systems Inc: Form 10-Q for the period ended Oct 31, 2013
Filed with the SEC on Dec 13, 2013 and accepted by EDGAR at Dec 13, 2013, 22:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-08-01 to 2013-10-31 | $55.0m | us-gaap:Revenues |
| Revenue | 9 months2013-02-01 to 2013-10-31 | $147.3m | us-gaap:Revenues |
| Cost of revenue | 3 months2013-08-01 to 2013-10-31 | $21.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2013-02-01 to 2013-10-31 | $58.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2013-08-01 to 2013-10-31 | $33.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2013-02-01 to 2013-10-31 | $89.1m | us-gaap:GrossProfit |
| Research and development | 3 months2013-08-01 to 2013-10-31 | $6.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2013-02-01 to 2013-10-31 | $18.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2013-08-01 to 2013-10-31 | $10.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2013-02-01 to 2013-10-31 | $28.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2013-08-01 to 2013-10-31 | $3.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2013-02-01 to 2013-10-31 | $10.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-08-01 to 2013-10-31 | $6.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2013-02-01 to 2013-10-31 | $17.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-08-01 to 2013-10-31 | $0.05 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2013-02-01 to 2013-10-31 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-08-01 to 2013-10-31 | $0.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2013-02-01 to 2013-10-31 | $0.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2013-08-01 to 2013-10-31 | 131,963,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2013-02-01 to 2013-10-31 | 129,601,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2013-08-01 to 2013-10-31 | $5.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 9 months2013-02-01 to 2013-10-31 | $25.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2013-08-01 to 2013-10-31 | $460.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 9 months2013-02-01 to 2013-10-31 | $1.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-10-31 | $257.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-10-31 | $328.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-10-31 | $345.3m | us-gaap:Assets |
| Current liabilities | At period end2013-10-31 | $70.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-10-31 | $74.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2013-10-31 | $270.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-13-473368. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.